depression
The digital therapeutic company purchased assets from Waypoint Health Innovations and from Örebro University researcher Fredrik Holländare.
The company’s digital therapeutic aimed at treating depression in teens, SparkRx, was launched in October.
The online platform being developed by USQ will help young people manage anxiety and depression.
They will develop and commercialise three novel digital therapeutic products.
HIMSS21
Using formerly siloed data, the juli app helps patients manage complex conditions such as asthma, depression, bipolar disorder, migraine and chronic pain, says juli.co CEO Bettina Hein.
AI algorithms will inform treatment decisions by recognising patterns of data from past treatments.
The company is releasing its research on mapping biomarkers for depression.
The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.
The company said its services are accessible to millions of people through partnerships with over 200 employers, health plans and other strategic partners.